Literature DB >> 461456

Monocyte metabolic activation in patients with rheumatoid arthritis.

N E Kay, S D Douglas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 461456     DOI： 10.3181/00379727-161-40541

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  9 in total

1.  Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation.

Authors:  J Lunec; D R Blake; S J McCleary; S Brailsford; P A Bacon
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis.

Authors:  E Flescher; T L Bowlin; A Ballester; R Houk; N Talal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

3.  Monocyte activation in early onset rheumatoid arthritis.

Authors:  I Fujii; M Shingu; M Nobunaga
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

4.  The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice.

Authors:  K Kakimoto; Y Kojima; K Ishii; K Onoue; H Maeda
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

5.  A serum antibody in patients with rheumatoid arthritis stimulates cathepsin B activity in peritoneal mouse macrophages.

Authors:  M Ostensen; B Mørland; G Husby; O P Rekvig
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

6.  Mononuclear phagocytes in rheumatoid arthritis: Fc-receptor expression by peripheral blood monocytes.

Authors:  S D Carter; J T Bourne; C J Elson; C W Hutton; R Czudek; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

7.  Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis.

Authors:  A Shore; S Jaglal; E C Keystone
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

8.  Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus.

Authors:  M Seitz; W Hunstein
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

9.  Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications.

Authors:  G D Kitas; M Salmon; M Farr; J S Gaston; P A Bacon
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.